| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/30/2000 | EP1030557A1 Protein delivery by secretory gland expression |
| 08/30/2000 | EP0837692B1 Clostridium difficile toxins and toxoids as mucosal adjuvants |
| 08/30/2000 | EP0759937B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 08/30/2000 | EP0671946B1 Immunoreactive peptides from epstein-barr virus |
| 08/30/2000 | EP0668772B1 Specific immune system modulation |
| 08/30/2000 | EP0642348B1 Antibiotic cryptdin peptides and methods of their use |
| 08/30/2000 | EP0631501B1 Glycosylation-mediated inhibition of factor x |
| 08/30/2000 | CN1265149A Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 08/30/2000 | CN1265112A Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| 08/30/2000 | CN1265038A Cellular vesicle called 'exosome', prepn. and use thereof in immune stimulation |
| 08/30/2000 | CN1055933C Polyclonal antibody, preparing process and use thereof |
| 08/29/2000 | US6111166 Transgenic mice expressing human Fcα and β receptors |
| 08/29/2000 | US6111089 Nucleic acid encoding a defined mouse amino acid sequence of a protein involved in embryo implantation; vaccine can be used as antifertility agent |
| 08/29/2000 | US6111078 Staphylococcus aureus rsbU-1 |
| 08/29/2000 | US6111074 Amino acid sequence of polypeptide from the uridine monophosphate kinase family; for screening bactericides and bacteriostats; for diagnosis and prophylaxis of infections |
| 08/29/2000 | US6111068 From the p-17 gag protein of human immunodeficiency virus; diagnosis; vaccines; viricides; prophylaxis and therapy for treating or suppressing acquired immune deficiency syndrome |
| 08/29/2000 | US6110899 LICC of Streptococcus pneumoniae |
| 08/29/2000 | US6110747 Compounds and methods for modulating tissue permeability |
| 08/29/2000 | US6110735 Method for the preparation of a viral vector by intermolecular homologous recombination |
| 08/29/2000 | US6110724 Rotavirus antigen, vaccine and diagnostic agent for rotavirus infections, and a method for producing the antigen |
| 08/29/2000 | US6110719 Phytase |
| 08/29/2000 | US6110706 Amino acid sequences; for increased immunogenicity |
| 08/29/2000 | US6110705 Recombinant Chlamydia trachomatis pgp3 fusion protein |
| 08/29/2000 | US6110704 3-ketoacyl-ACP-reductase (FabG) of Staphylococcus aureus |
| 08/29/2000 | US6110685 Polynucleotide sequence coding translational activation polypeptide; for prevention of infecttion; bactericides; microbicides |
| 08/29/2000 | US6110492 Immunogenic compositions |
| 08/29/2000 | US6110470 Dna molecules with encoded polypeptides with amino acid sequences |
| 08/29/2000 | US6110469 Hybrid plasmid for 38 kDa antigen of M. tuberculosis |
| 08/29/2000 | US6110468 Respiratory syndrome virus for swine |
| 08/29/2000 | US6110467 Isolated porcine respiratory and reproductive virus, vaccines and methods of protecting a pig against a disease caused by a porcine respiratory and reproductive virus |
| 08/29/2000 | US6110466 Modified plant viruses as vectors |
| 08/29/2000 | US6110465 Nucleotide and deduced amino acid sequences of hypervariable region 1 of the envelope 2 gene of isolates of hepatitis C virus and the use of reagents derived from these hypervariable sequences in diagnostic methods and vaccines |
| 08/29/2000 | US6110463 Anti-Cryptosporidium parvum preparations |
| 08/29/2000 | US6110458 Cancer therapy utilizing ex vivo gene transduction |
| 08/29/2000 | US6110457 Single stranded rna hybrid virus |
| 08/29/2000 | US6110161 Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle |
| 08/29/2000 | CA2010275C Pancreatic islet cell antigens obtained by molecular cloning |
| 08/29/2000 | CA2010164C Anthracycline immunoconjugates having a novel linker and methods for their production |
| 08/24/2000 | WO2000049146A1 Malaria vaccine |
| 08/24/2000 | WO2000049045A1 Peptide variants of the tumour marker muc1 and the use thereof |
| 08/24/2000 | WO2000049044A1 Expression of helicobacter polypeptides in pichia pastoris |
| 08/24/2000 | WO2000049043A2 Human lipid-associated proteins |
| 08/24/2000 | WO2000049042A1 nadE |
| 08/24/2000 | WO2000049038A2 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 08/24/2000 | WO2000049033A1 yybQ |
| 08/24/2000 | WO2000048681A2 Co-administration of a thrombolytic and an anti-cd18 antibody |
| 08/24/2000 | WO2000048638A2 Multi-mutant diphtheria toxin vaccines |
| 08/24/2000 | WO2000048631A2 Adjuvant and cell maturation agent |
| 08/24/2000 | WO2000048630A1 Immunogenic complexes and methods relating thereto |
| 08/24/2000 | WO2000048629A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
| 08/24/2000 | WO2000048628A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
| 08/24/2000 | WO2000048625A2 Inhibitors for use in hemostasis and immune function |
| 08/24/2000 | WO2000048620A1 Yeast cell wall peptides and antibodies thereto |
| 08/24/2000 | WO2000048615A2 TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE) |
| 08/24/2000 | WO2000048614A2 Method for producing anti-tumor th1 cells |
| 08/24/2000 | WO2000048462A1 Method for inhibiting transplant rejection |
| 08/24/2000 | WO2000032205A8 Immunomodulatory methods using carbohydrate antigens |
| 08/24/2000 | WO2000029554A3 Compositions for preserving haptenized tumor cells for use in vaccines |
| 08/24/2000 | WO2000022134A3 Test kit for diagnosis of borrelia infection and novel borrelia antigens for the development of vaccines |
| 08/24/2000 | WO2000020434A9 Cadherin-like asymmetry protein-1, and methods for its use |
| 08/24/2000 | WO2000015797A3 Compositions and methods for the treatment of immune related diseases |
| 08/24/2000 | WO2000015251A3 Influenza virus vaccine composition |
| 08/24/2000 | WO2000004917A9 USE OF HC gp-39 IN IMMUNE DISEASES |
| 08/24/2000 | WO1999057280A3 Neisseria meningitidis antigens and compositions |
| 08/24/2000 | WO1999040938A3 Vaccines comprising interleukin-12 and herpes simplex viral antigen |
| 08/24/2000 | WO1998024898A3 Therapeutic composition comprising the kal protein and use of the kal protein |
| 08/24/2000 | WO1998000439A3 Multivalent compounds for cross-linking receptors and uses thereof |
| 08/24/2000 | DE4193302C2 Verwendung rekombinanter Antikörper spezifisch für TNF-alpha Using recombinant antibody specific for TNF-alpha |
| 08/24/2000 | DE19906744A1 Pharmaceutical composition useful for tumor therapy comprises tumor-reactive helper T cells that produce high levels of interferon gamma and little or no interleukin-4 |
| 08/24/2000 | CA2372059A1 Use of an ompa enterobacterium protein associated with the elagigiltv peptide for treating melanomas |
| 08/24/2000 | CA2371799A1 Yeast cell wall peptides and antibodies thereto |
| 08/24/2000 | CA2368309A1 Peptide variants of the tumour marker muc1 and the use thereof |
| 08/24/2000 | CA2362807A1 Multi-mutant diphtheria toxin vaccines |
| 08/24/2000 | CA2362300A1 Human lipid-associated proteins |
| 08/24/2000 | CA2362192A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
| 08/24/2000 | CA2362161A1 Method for inhibiting transplant rejection |
| 08/24/2000 | CA2361925A1 Treatment of chronic viral infections with m. vaccae |
| 08/24/2000 | CA2361273A1 Inhibitors for use in hemostasis and immune function |
| 08/24/2000 | CA2359610A1 Malaria vaccine |
| 08/24/2000 | CA2262056A1 Composition, methods and reagents for the synthesis of a soluble form of human pex |
| 08/23/2000 | EP1029870A2 Hybrid Immunoglobulins |
| 08/23/2000 | EP1029549A1 Formulation of nucleic acids and acemannan |
| 08/23/2000 | EP1029536A1 Buccal non-polar spray |
| 08/23/2000 | EP1029246A1 A method and device for preventing immunoglobulin degradation in external secretions |
| 08/23/2000 | EP1029080A1 Human blood bacterium |
| 08/23/2000 | EP1029068A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 08/23/2000 | EP1029054A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene |
| 08/23/2000 | EP1029053A1 Nucleic acid fragments and polypeptide fragments derived from mycobacterium tuberculosis |
| 08/23/2000 | EP1029052A2 Neisserial antigens |
| 08/23/2000 | EP1029050A1 Tumor-specific antigens, methods for their production and their use for immunization and diagnosis |
| 08/23/2000 | EP1029044A1 Tissue cement proteins from rhipicephalus appendiculatus |
| 08/23/2000 | EP1029043A1 Human receptor proteins; related reagents and methods |
| 08/23/2000 | EP1028978A2 Glycosylated antibodies and antibody fragments having reactive ketone groups |
| 08/23/2000 | EP1028974A1 Secreted proteins and polynucleotides encoding them |
| 08/23/2000 | EP1028973A1 IgG-BINDING PROTEIN FROM $i(STAPHYLOCOCCUS) AND NUCLEOTIDE SEQUENCE ENCODING THIS PROTEIN |
| 08/23/2000 | EP1028972A2 MULTI-MER PEPTIDES DERIVED FROM $i(HEPATITIS C VIRUS) ENVELOPE PROTEINS FOR DIAGNOSTIC USE AND VACCINATION PURPOSES |
| 08/23/2000 | EP1028751A1 Methods and compositions comprising glycoprotein glycoforms |
| 08/23/2000 | EP1028750A1 Multivalent vaccines |
| 08/23/2000 | EP1028749A1 Enterococcus antigens and vaccines |
| 08/23/2000 | EP1028743A1 TREATMENT AND DIAGNOSIS OF INFERTILITY USING TGF$g(b) OR ACTIVIN |